EU watchdog could approve Merck Covid pill 'within weeks'

Covid pill Molnupiravir

The European Medicines Agency said on November 23, 2021 it may decide "within weeks" whether to approve Merck's anti-Covid pill, Lagevrio.

Photo credit: Handout | Merck & Co, Inc. | AFP

The Hague

Welcome!

You're all set to enjoy unlimited Prime content.